Sun Pharma Expands Global Oncology Portfolio with $355 Million Acquisition of Checkpoint Therapeutics
Sun Pharma, India's largest drugmaker, is set to acquire Checkpoint Therapeutics for $355 million, enhancing its oncology portfolio with FDA-approved UNLOXCYT for advanced skin can...